BRIEF-Alvotech And Teva Announce Filing Acceptance Of U.S. Biologics License Application
ReutersFeb 18, 2025 11:19 AM
Feb 18 (Reuters) - Alvotech SA ALVO.O:
ALVOTECH AND TEVA ANNOUNCE FILING ACCEPTANCE OF U.S. BIOLOGICS LICENSE APPLICATION FOR AVT06, A PROPOSED BIOSIMILAR TO EYLEA® (AFLIBERCEPT)
ALVOTECH SA - REGULATORY APPROVAL FOR AVT06 EXPECTED BY Q4 2025
Source text: ID:nGNX1fKZpR
Further company coverage: ALVO.O
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Could Buying MP Materials Today Set You Up for Life?
Key PointsMP Materials' share price has surged on the heels of strategic partnerships with Apple and the Department of Defense. The company owns the only mining and processing site in the U.S. for rare-earth elements.Continued growth will depend on its ability to generate revenue, which in turn...The Motley Fool
11 hours ago
Nvidia Stock Slips After Earnings. 2 Crucial Things Investors May Be Ignoring.
Key PointsNvidia beat analysts' earnings expectations, but revenue is growing more slowly than it did earlier in the AI boom.It's important to dig into the details and consider the company's long-term prospects.10 stocks we like better than Nvidia › Nvidia (NASDAQ: NVDA) is known for beating...The Motley Fool
11 hours ago
Contrarian Series: With Oil Prices Hitting a Four-Year Low, Is a Trend Reversal on the Horizon?
TradingKey - As markets worldwide hold their breath ahead of the Federal Reserve’s September FOMC meeting, uncertainty mirrors that of exactly one year ago, when the Fed unexpectedly cut rates by 50 bps. Although Jerome Powell struck a relatively dovish tone at recent global central...TradingKey
12 hours ago
[Crypto IPO] Trump Family Adds New Player: American Bitcoin Aims for Nasdaq Listing in September
American Bitcoin is set to make its debut on Nasdaq this September, marking another strategic expansion of the Trump family’s cryptocurrency ventures.TradingKey
15 hours ago
Eurozone Q2 GDP Commentary: Will the Euro's Upward Momentum Persist?
TradingKey - On 14 August 2025, Eurostat published Q2 GDP figures, revealing a drop in the Eurozone's quarter-on-quarter growth from 0.6% in the first quarter to 0.1%. Consequently, annual growth eased from 1.5% to 1.4%. The slowdown primarily stems from the diminishing boost from European...TradingKey
Mon, Aug 18
